10.6084/m9.figshare.11364047.v1
Cynthia Shu
Cynthia
Shu
Ariana Kaxon-Rupp
Ariana
Kaxon-Rupp
Judd Collado
Judd
Collado
Robert Damoiseaux
Robert
Damoiseaux
Rachelle Crosbie
Rachelle
Crosbie
MOESM4 of Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy
Springer Nature
2019
Drug discovery
Duchenne muscular dystrophy
C2C12
Dystrophin
Felodipine
High-throughput screen
Sarcolemma
Sarcospan
Small molecules
2019-12-13 07:39:47
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/MOESM4_of_Development_of_a_high-throughput_screen_to_identify_small_molecule_enhancers_of_sarcospan_for_the_treatment_of_Duchenne_muscular_dystrophy/11364047
Additional file 4: Figure S2. C2C12 myoblasts undergoing differentiation and fusion into myotubes. Confluent C2C12 myoblasts (day 0, D0) were switched from proliferation to differentiation media and imaged daily using phase contrast microscopy for 7 days (D1 to D7). Scale bar = 200 μm.